Comparison of Hip Fracture Risk Between Zolpidem and Zopiclone in Older Adults
Human Psychopharmacology: Clinical and Experimental · 2026-05 · 41 (3)
DOI: 10.1002/hup.70038 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 30.03.2026. Verfasst von Shih-Wei Lai und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Hip Fractures, Zolpidem, Hypnotics and Sedatives, Azabicyclo Compounds. Die Arbeit nennt 15 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
Zolpidem and zopiclone are widely prescribed hypnotics for older adults, yet their comparative safety regarding hip fracture risk remains unclear. This study aimed to compare the risk of hip fracture between zolpidem and zopiclone among adults aged 65–84 years.
Methods
Electronic health records from 166 global healthcare organizations in the TriNetX platform were analyzed. Adults aged 65–84 years who were newly prescribed zolpidem or zopiclone were identified. Propensity score matching was used to balance baseline characteristics. The TriNetX “Compare Outcomes” tool was used to estimate the cumulative incidence of hip fracture, hazard ratio, and 95% confidence interval between zolpidem users and zopiclone users.
Results
After propensity score matching, 41,500 adults were included in each group. During the 1‐year follow‐up period, 100 adults in the zolpidem group and 174 adults in the zopiclone group experienced a hip fracture, corresponding to cumulative incidences of 0.24% and 0.42%, respectively. In the Cox proportional hazards regression model, zolpidem use was associated with a reduced risk of hip fracture (hazard ratio 0.51; 95% confidence interval, 0.40–0.66).
Conclusion
Zolpidem was associated with a lower risk of hip fracture compared with zopiclone among adults aged 65–84 years. These findings highlight the need for further research to confirm these differences and explore underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, China Medical University, Taichung, Taiwan.
- Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
- Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan.
ORCID-Profile: Shih-Wei Lai
Zitieren
APA
Lai, S. W., & Liao, K. F. (2026). Comparison of Hip Fracture Risk Between Zolpidem and Zopiclone in Older Adults. Human Psychopharmacology: Clinical and Experimental, 41(3). https://doi.org/10.1002/hup.70038
Vancouver
Lai SW, Liao KF. Comparison of Hip Fracture Risk Between Zolpidem and Zopiclone in Older Adults. Human Psychopharmacology: Clinical and Experimental. 2026;41(3). doi:10.1002/hup.70038
BibTeX
@article{Lai2026,
author = {Lai, Shih-Wei and Liao, Kuan-Fu},
title = {Comparison of Hip Fracture Risk Between Zolpidem and Zopiclone in Older Adults},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2026},
volume = {41},
number = {3},
doi = {10.1002/hup.70038}
}
EUVIMED